Inside your body, hormones constantly shape when you feel hungry, how satisfied you feel after eating, and how efficiently your body handles sugar and energy
Following a single 50 mg dose of [14C]-dapagliflozin, 75% and 21% total radioactivity is excreted in urine and feces, respectively
Everyone responds differently when they stop taking their medication, Adeyemo says
There are two specific safety risks with compounded injectable GLP-1s that go beyond standard medication side effects, and both have been the subject of public regulatory and legal attention in 2025-2026
Kang et al., 2007
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis KEY MARKET PLAYERS Novo Nordisk A/S (Denmark) Eli Lilly and Company (US) Sanofi (France) Hansoh Pharmaceutical Group Co., Ltd